LCDX (Caliber Imaging & Diagnostics) EBITDA Margin %: -184.97% (As of Mar. 2014)


What is Caliber Imaging & Diagnostics EBITDA Margin %?

Caliber Imaging & Diagnostics LCDX EBITDA Margin % is -184.97% as of Mar. 2014.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Caliber Imaging & Diagnostics's EBITDA for the three months ended in Mar. 2014 was $-1.59 Mil. Caliber Imaging & Diagnostics's Revenue for the three months ended in Mar. 2014 was $0.86 Mil. Therefore, Caliber Imaging & Diagnostics's EBITDA margin for the quarter that ended in Mar. 2014 was -184.97%.

Caliber Imaging & Diagnostics  (OTCPK:LCDX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Caliber Imaging & Diagnostics EBITDA Margin % Related Terms

Caliber Imaging & Diagnostics EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Caliber Imaging & Diagnostics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caliber Imaging & Diagnostics EBITDA Margin % Chart

Caliber Imaging & Diagnostics Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13
EBITDA Margin %
-151.02 -142.33 -180.82 -386.74 -140.17

Caliber Imaging & Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -85.55 -210.27 -234.10 -89.49 -184.97

LCDX vs VICA, CRVW, RSLS: EBITDA Margin % Comparison

For the Medical Devices subindustry, Caliber Imaging & Diagnostics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caliber Imaging & Diagnostics EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Caliber Imaging & Diagnostics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Caliber Imaging & Diagnostics's EBITDA Margin % falls into.


Caliber Imaging & Diagnostics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Caliber Imaging & Diagnostics's EBITDA Margin % for the fiscal year that ended in Dec. 2013 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2013 )/Revenue (A: Dec. 2013 )
=-4.683/3.341
=-140.17 %

Caliber Imaging & Diagnostics's EBITDA Margin % for the quarter that ended in Mar. 2014 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2014 )/Revenue (Q: Mar. 2014 )
=-1.587/0.858
=-184.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -184.97% mean?
Caliber Imaging & Diagnostics (LCDX) has a EBITDA Margin % of -184.97% as of Mar. 2014. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Caliber Imaging & Diagnostics and its competitors.
Is Caliber Imaging & Diagnostics' EBITDA Margin % too high?
Caliber Imaging & Diagnostics' current EBITDA Margin % is -184.97%.
How does Caliber Imaging & Diagnostics' EBITDA Margin % compare to VICA and CRVW?
Caliber Imaging & Diagnostics' EBITDA Margin % of -184.97% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Caliber Imaging & Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Caliber Imaging & Diagnostics's current EBITDA Margin % is -184.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caliber Imaging & Diagnostics stock overvalued right now?
Caliber Imaging & Diagnostics (LCDX) has a current EBITDA Margin % of -184.97%. The current EBITDA Margin % is -184.97%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Caliber Imaging & Diagnostics (LCDX), the current EBITDA Margin % is -184.97% as of Mar. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caliber Imaging & Diagnostics Business Description

Address 50 Methodist Hill Drive, Suite 1000, Rochester, NY, USA, 14623
Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.